Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $83.71 | 5 | 84.4% |
| Education | $15.45 | 1 | 15.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $24.29 | 2 | $0 (2018) |
| SOBI, INC | $22.46 | 1 | $0 (2024) |
| Resmed Corp | $19.55 | 1 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $17.41 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $15.45 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.46 | 1 | SOBI, INC ($22.46) |
| 2021 | $17.41 | 1 | JAZZ PHARMACEUTICALS INC. ($17.41) |
| 2020 | $15.45 | 1 | AstraZeneca Pharmaceuticals LP ($15.45) |
| 2018 | $43.84 | 3 | Philips Electronics North America Corporation ($24.29) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/16/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: NEUROLOGY | ||||||
| 11/10/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Education | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 08/08/2018 | Philips Electronics North America Corporation | Trilogy 100 (Device) | Food and Beverage | Cash or cash equivalent | $11.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/19/2018 | Philips Electronics North America Corporation | S&RC Und (Device) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2018 | Resmed Corp | Activox (Device) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 124 | 134 | $65,919 | $8,677 |
| 2022 | 7 | 215 | 225 | $79,593 | $12,724 |
| 2021 | 10 | 360 | 383 | $125,224 | $22,766 |
| 2020 | 9 | 325 | 350 | $112,775 | $18,508 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 40 | 43 | $41,065 | $4,049 | 9.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 27 | 33 | $2,414 | $1,555 | 64.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 16 | 16 | $14,592 | $1,361 | 9.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,768 | $1,139 | 41.2% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 20 | 20 | $5,080 | $573.76 | 11.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 43 | 45 | $42,975 | $4,230 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 46 | $5,864 | $2,588 | 44.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 22 | 23 | $20,976 | $2,136 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 42 | $3,356 | $2,024 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 18 | $2,124 | $1,351 | 63.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 19 | 19 | $1,558 | $167.64 | 10.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 20 | 20 | $1,660 | $130.71 | 7.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 12 | 12 | $1,080 | $95.36 | 8.8% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 64 | 66 | $61,910 | $6,044 | 9.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 59 | $7,234 | $3,669 | 50.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 51 | 63 | $5,010 | $2,979 | 59.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 42 | $4,759 | $2,890 | 60.7% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 32 | 32 | $28,752 | $2,694 | 9.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 21 | 21 | $3,280 | $2,088 | 63.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 13 | $2,311 | $1,112 | 48.1% |
| 95800 | Study of sleep patterns, including sleep time | Facility | 2021 | 20 | 20 | $4,984 | $517.76 | 10.4% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Facility | 2021 | 12 | 12 | $2,426 | $421.44 | 17.4% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 18 | 18 | $1,443 | $132.86 | 9.2% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 20 | 20 | $1,621 | $112.16 | 6.9% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 17 | 17 | $1,494 | $105.43 | 7.1% |
About Dr. Michael Mccubbin, M.D
Dr. Michael Mccubbin, M.D is a Allergy healthcare provider based in Pella, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790708451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mccubbin, M.D has received a total of $99.16 in payments from pharmaceutical and medical device companies, with $22.46 received in 2024. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($83.71).
As a Medicare-enrolled provider, Mccubbin has provided services to 1,024 Medicare beneficiaries, totaling 1,092 services with total Medicare billing of $62,675. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Other Specialties Pediatric Pulmonology, Sleep Medicine
- Location Pella, IA
- Active Since 07/25/2006
- Last Updated 03/26/2014
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1790708451
Products in Payments
- VONJO (Drug) $22.46
- Activox (Device) $19.55
- XYWAV (Drug) $17.41
- BREZTRI AEROSPHERE (Drug) $15.45
- S&RC Und (Device) $12.65
- Trilogy 100 (Device) $11.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.